182 related articles for article (PubMed ID: 35681561)
1. Targeting MUC1-C Suppresses Chronic Activation of Cytosolic Nucleotide Receptors and STING in Triple-Negative Breast Cancer.
Yamashita N; Fushimi A; Morimoto Y; Bhattacharya A; Hagiwara M; Yamamoto M; Hata T; Shapiro GI; Long MD; Liu S; Kufe D
Cancers (Basel); 2022 May; 14(11):. PubMed ID: 35681561
[TBL] [Abstract][Full Text] [Related]
2. MUC1-C Dictates PBRM1-Mediated Chronic Induction of Interferon Signaling, DNA Damage Resistance, and Immunosuppression in Triple-Negative Breast Cancer.
Yamashita N; Morimoto Y; Fushimi A; Ahmad R; Bhattacharya A; Daimon T; Haratake N; Inoue Y; Ishikawa S; Yamamoto M; Hata T; Akiyoshi S; Hu Q; Liu T; Withers H; Liu S; Shapiro GI; Yoshizumi T; Long MD; Kufe D
Mol Cancer Res; 2023 Mar; 21(3):274-289. PubMed ID: 36445328
[TBL] [Abstract][Full Text] [Related]
3. MUC1-C integrates activation of the IFN-γ pathway with suppression of the tumor immune microenvironment in triple-negative breast cancer.
Yamashita N; Long M; Fushimi A; Yamamoto M; Hata T; Hagiwara M; Bhattacharya A; Hu Q; Wong KK; Liu S; Kufe D
J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33495298
[TBL] [Abstract][Full Text] [Related]
4. Human Cancer Cells Sense Cytosolic Nucleic Acids Through the RIG-I-MAVS Pathway and cGAS-STING Pathway.
Qiao Y; Zhu S; Deng S; Zou SS; Gao B; Zang G; Wu J; Jiang Y; Liu YJ; Chen J
Front Cell Dev Biol; 2020; 8():606001. PubMed ID: 33490069
[TBL] [Abstract][Full Text] [Related]
5. Addiction of Cancer Stem Cells to MUC1-C in Triple-Negative Breast Cancer Progression.
Yamashita N; Kufe D
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897789
[TBL] [Abstract][Full Text] [Related]
6. Targeting MUC1-C suppresses BCL2A1 in triple-negative breast cancer.
Hiraki M; Maeda T; Mehrotra N; Jin C; Alam M; Bouillez A; Hata T; Tagde A; Keating A; Kharbanda S; Singh H; Kufe D
Signal Transduct Target Ther; 2018; 3():13. PubMed ID: 29760958
[TBL] [Abstract][Full Text] [Related]
7. The cGAS-STING signaling in cardiovascular and metabolic diseases: Future novel target option for pharmacotherapy.
Oduro PK; Zheng X; Wei J; Yang Y; Wang Y; Zhang H; Liu E; Gao X; Du M; Wang Q
Acta Pharm Sin B; 2022 Jan; 12(1):50-75. PubMed ID: 35127372
[TBL] [Abstract][Full Text] [Related]
8. Aryl hydrocarbon receptor suppresses STING-mediated type I IFN expression in triple-negative breast cancer.
Martin JC; da Silva Fernandes T; Chaudhry KA; Oshi M; Abrams SI; Takabe K; Rosario SR; Bianchi-Smiraglia A
Sci Rep; 2024 Mar; 14(1):5731. PubMed ID: 38459088
[TBL] [Abstract][Full Text] [Related]
9. MUC1-C integrates type II interferon and chromatin remodeling pathways in immunosuppression of prostate cancer.
Hagiwara M; Fushimi A; Bhattacharya A; Yamashita N; Morimoto Y; Oya M; Withers HG; Hu Q; Liu T; Liu S; Wong KK; Long MD; Kufe D
Oncoimmunology; 2022; 11(1):2029298. PubMed ID: 35127252
[TBL] [Abstract][Full Text] [Related]
10. Baculovirus Transduction in Mammalian Cells Is Affected by the Production of Type I and III Interferons, Which Is Mediated Mainly by the cGAS-STING Pathway.
Amalfi S; Molina GN; Bevacqua RJ; López MG; Taboga O; Alfonso V
J Virol; 2020 Oct; 94(21):. PubMed ID: 32796076
[TBL] [Abstract][Full Text] [Related]
11. MUC1-C Integrates Chromatin Remodeling and PARP1 Activity in the DNA Damage Response of Triple-Negative Breast Cancer Cells.
Yamamoto M; Jin C; Hata T; Yasumizu Y; Zhang Y; Hong D; Maeda T; Miyo M; Hiraki M; Suzuki Y; Hinohara K; Rajabi H; Kufe D
Cancer Res; 2019 Apr; 79(8):2031-2041. PubMed ID: 30824588
[TBL] [Abstract][Full Text] [Related]
12. IFN-γ activates the tumor cell-intrinsic STING pathway through the induction of DNA damage and cytosolic dsDNA formation.
Xiong H; Xi Y; Yuan Z; Wang B; Hu S; Fang C; Cai Y; Fu X; Li L
Oncoimmunology; 2022; 11(1):2044103. PubMed ID: 35273829
[TBL] [Abstract][Full Text] [Related]
13. MUC1-C Represses the Crumbs Complex Polarity Factor CRB3 and Downregulates the Hippo Pathway.
Alam M; Bouillez A; Tagde A; Ahmad R; Rajabi H; Maeda T; Hiraki M; Suzuki Y; Kufe D
Mol Cancer Res; 2016 Dec; 14(12):1266-1276. PubMed ID: 27658423
[TBL] [Abstract][Full Text] [Related]
14. CAR T Cells Targeting the Tumor MUC1 Glycoprotein Reduce Triple-Negative Breast Cancer Growth.
Zhou R; Yazdanifar M; Roy LD; Whilding LM; Gavrill A; Maher J; Mukherjee P
Front Immunol; 2019; 10():1149. PubMed ID: 31178870
[TBL] [Abstract][Full Text] [Related]
15. Apoptosis-derived membrane vesicles drive the cGAS-STING pathway and enhance type I IFN production in systemic lupus erythematosus.
Kato Y; Park J; Takamatsu H; Konaka H; Aoki W; Aburaya S; Ueda M; Nishide M; Koyama S; Hayama Y; Kinehara Y; Hirano T; Shima Y; Narazaki M; Kumanogoh A
Ann Rheum Dis; 2018 Oct; 77(10):1507-1515. PubMed ID: 29945921
[TBL] [Abstract][Full Text] [Related]
16. A STING to inflammation and autoimmunity.
Kumar V
J Leukoc Biol; 2019 Jul; 106(1):171-185. PubMed ID: 30990921
[TBL] [Abstract][Full Text] [Related]
17. African Swine Fever Virus Armenia/07 Virulent Strain Controls Interferon Beta Production through the cGAS-STING Pathway.
García-Belmonte R; Pérez-Núñez D; Pittau M; Richt JA; Revilla Y
J Virol; 2019 Jun; 93(12):. PubMed ID: 30918080
[TBL] [Abstract][Full Text] [Related]
18. STING agonist diABZI induces PANoptosis and DNA mediated acute respiratory distress syndrome (ARDS).
Messaoud-Nacer Y; Culerier E; Rose S; Maillet I; Rouxel N; Briault S; Ryffel B; Quesniaux VFJ; Togbe D
Cell Death Dis; 2022 Mar; 13(3):269. PubMed ID: 35338116
[TBL] [Abstract][Full Text] [Related]
19. Unabated adenovirus replication following activation of the cGAS/STING-dependent antiviral response in human cells.
Lam E; Falck-Pedersen E
J Virol; 2014 Dec; 88(24):14426-39. PubMed ID: 25297994
[TBL] [Abstract][Full Text] [Related]
20. Herpes Simplex Virus 1 Abrogates the cGAS/STING-Mediated Cytosolic DNA-Sensing Pathway via Its Virion Host Shutoff Protein, UL41.
Su C; Zheng C
J Virol; 2017 Mar; 91(6):. PubMed ID: 28077645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
